Ocrevus (ocrelizumab)

pCPA File Number: 21003
Negotiation Status:
Concluded with an LOI
Indication(s):
multiple sclerosis, relapsing
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
SR0519-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: